Long-acting injectable antiretrovirals for HIV treatment: A multi-site qualitative Study of Clinic-Level Barriers to Implementation in the United States
T McCrimmon, LF Collins, A Perez-Brumer… - AIDS patient care and …, 2024 - liebertpub.com
Long-acting injectable antiretroviral therapy (LAI ART) has the potential to address
adherence obstacles associated with daily oral ART, leading to enhanced treatment uptake …
adherence obstacles associated with daily oral ART, leading to enhanced treatment uptake …
Voluntary licensing of long‐acting HIV prevention and treatment regimens: using a proven collaboration‐and competition‐based mechanism to rapidly expand at …
L Gaayeb, A Das, I James, R Murthy… - Journal of the …, 2023 - Wiley Online Library
Introduction Emerging long‐acting (LA) prevention and treatment medicines, technologies
and regimens could be game‐changing for the HIV response, helping reach the ambitious …
and regimens could be game‐changing for the HIV response, helping reach the ambitious …
[PDF][PDF] Long-Acting HIV Medicines and the Pandemic Inequality Cycle—Rethinking Access
W Byanyima, LG Bekker, MM Kavanagh - The New England journal of …, 2024 - natap.org
The world may look back on 2024 as a pivotal time in the fight against AIDS—the start of a
revolution in the global biomedical response to HIV using long-acting antiretroviral …
revolution in the global biomedical response to HIV using long-acting antiretroviral …
Denying access to long-acting injectable treatment for HIV: an open letter
UNAIDS targets seek to ensure that 95% of people living with HIV know their status, 95% of
those diagnosed receive sustained antiretroviral therapy (ART), and 95% of those on …
those diagnosed receive sustained antiretroviral therapy (ART), and 95% of those on …